ATE380821T1 - Zytotoxische depsipeptide - Google Patents

Zytotoxische depsipeptide

Info

Publication number
ATE380821T1
ATE380821T1 AT04743045T AT04743045T ATE380821T1 AT E380821 T1 ATE380821 T1 AT E380821T1 AT 04743045 T AT04743045 T AT 04743045T AT 04743045 T AT04743045 T AT 04743045T AT E380821 T1 ATE380821 T1 AT E380821T1
Authority
AT
Austria
Prior art keywords
sub
depsipeptides
cytotoxic
cytotoxic depsipeptides
cancers
Prior art date
Application number
AT04743045T
Other languages
English (en)
Inventor
Paco Romero
Leyre Malet
Librada Canedo
Carmen Cuevas
Reyes Jose Fernando
Original Assignee
Inst Biomar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biomar Sa filed Critical Inst Biomar Sa
Application granted granted Critical
Publication of ATE380821T1 publication Critical patent/ATE380821T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT04743045T 2003-06-24 2004-06-23 Zytotoxische depsipeptide ATE380821T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314726.1A GB0314726D0 (en) 2003-06-24 2003-06-24 New cytotoxic depsipeptides

Publications (1)

Publication Number Publication Date
ATE380821T1 true ATE380821T1 (de) 2007-12-15

Family

ID=27637250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743045T ATE380821T1 (de) 2003-06-24 2004-06-23 Zytotoxische depsipeptide

Country Status (20)

Country Link
US (1) US7446094B2 (de)
EP (1) EP1644403B1 (de)
JP (1) JP4554606B2 (de)
KR (1) KR20060035633A (de)
CN (1) CN100448889C (de)
AT (1) ATE380821T1 (de)
AU (1) AU2004251103A1 (de)
CA (1) CA2529371A1 (de)
DE (1) DE602004010667T2 (de)
DK (1) DK1644403T3 (de)
EA (1) EA010585B1 (de)
ES (1) ES2297441T3 (de)
GB (1) GB0314726D0 (de)
IL (1) IL172538A (de)
MX (1) MXPA05013946A (de)
NO (1) NO20060361L (de)
NZ (1) NZ544066A (de)
PL (1) PL1644403T3 (de)
PT (1) PT1644403E (de)
WO (1) WO2005000880A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006160723A (ja) * 2004-11-10 2006-06-22 Marine Biotechnol Inst Co Ltd 抗腫瘍活性を有する化合物及びその製造方法
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
JP2010535204A (ja) * 2007-08-02 2010-11-18 ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー 治療用化合物
US8796300B2 (en) 2009-11-05 2014-08-05 Rutgers, The State University Of New Jersey Therapeutic compounds
WO2012162512A1 (en) * 2011-05-26 2012-11-29 Novobiotic Pharmaceuticals Llc Novel antibiotics
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11180997A (ja) * 1997-12-24 1999-07-06 Yamanouchi Pharmaceut Co Ltd 新規抗腫瘍化合物

Also Published As

Publication number Publication date
US20080227765A9 (en) 2008-09-18
NZ544066A (en) 2008-04-30
EP1644403A2 (de) 2006-04-12
CN1839148A (zh) 2006-09-27
DE602004010667T2 (de) 2008-12-11
CN100448889C (zh) 2009-01-07
DE602004010667D1 (de) 2008-01-24
JP2007536196A (ja) 2007-12-13
CA2529371A1 (en) 2005-01-06
WO2005000880A3 (en) 2005-08-04
MXPA05013946A (es) 2006-03-09
US20070082878A1 (en) 2007-04-12
DK1644403T3 (da) 2008-05-05
IL172538A (en) 2010-02-17
ES2297441T3 (es) 2008-05-01
WO2005000880A2 (en) 2005-01-06
EA200600092A1 (ru) 2006-06-30
AU2004251103A1 (en) 2005-01-06
JP4554606B2 (ja) 2010-09-29
EA010585B1 (ru) 2008-10-30
GB0314726D0 (en) 2003-07-30
KR20060035633A (ko) 2006-04-26
US7446094B2 (en) 2008-11-04
NO20060361L (no) 2006-03-08
PL1644403T3 (pl) 2008-05-30
IL172538A0 (en) 2006-04-10
PT1644403E (pt) 2008-03-12
EP1644403B1 (de) 2007-12-12

Similar Documents

Publication Publication Date Title
CY1109385T1 (el) Αναστολεις γυρασης και χρησεις αυτων
IS6658A (is) Ný efnasambönd
SE0302811D0 (sv) Novel compounds
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
TNSN06071A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
SE0301700D0 (sv) Novel compounds
ATE484508T1 (de) Furylverbindungen
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
SE0302139D0 (sv) Novel compounds
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
CY1110332T1 (el) Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους
NO20060361L (no) Nye cytotoxiske depsipeptider
SE0303541D0 (sv) New compounds
HRPK20041072B3 (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
SE0003476D0 (sv) Compounds
SE0303280D0 (sv) Novel compounds
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
SE0303090D0 (sv) Novel compounds
SE0302755D0 (sv) Novel compounds
BRPI0415355A (pt) triarilimidazóis
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
MX2008001548A (es) Compuestos antitumorales.
UY26498A1 (es) Pirroles sustituidos
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1644403

Country of ref document: EP

REN Ceased due to non-payment of the annual fee